Healthcare & Life Sciences
Bugworks
India
series-b
series-b
Stage
1
Investors
About
Bugworks develops antibiotic discovery technologies to overcome efflux-mediated drug resistance and enable entry of antibiotics into Gram-negative pathogens, with multiple novel antibacterial chemical series currently in clinical stages.
Explore Bugworks's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.